Ilomastat (GM6001) Mechanism of Action: MMP-9 Inhibition in Tumor Cells Research

Ilomastat (GM6001) MOA:Targeting MMP-9/ECM Degradation Pathway for Oncology Research

🎯 check Ilomastat (GM6001) product page

Ilomastat (GM6001) is a potent, broad-spectrum matrix metalloproteinase (MMP) inhibitor. It affects EGFR and RhoA/Rac1 signaling pathways by blocking MMP-mediated extracellular matrix degradation and protein shedding, effectively inhibiting cell migration, invasion, and tissue remodeling.

Primary Applications and Mechanism of Action